What is the maximum dose of vancomycin (Vancomycin hydrochloride) in pediatric patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 28, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Maximum Dose of Vancomycin in Pediatric Patients

The maximum dose of vancomycin in pediatric patients is 60 mg/kg/day, typically divided into 2-4 doses depending on the indication and patient age. 1, 2

General Dosing Guidelines

  • For most pediatric patients, vancomycin is dosed at 40-60 mg/kg/day divided into 3-4 doses (every 6-8 hours) 1, 2
  • For neonates and infants up to 1 month of age, lower doses are recommended: an initial dose of 15 mg/kg followed by 10 mg/kg every 12 hours in the first week of life, and every 8 hours thereafter 1
  • For specific infections like methicillin-resistant Staphylococcus aureus (MRSA), dosing at the higher end of the range (40-60 mg/kg/day) is recommended 2

Indication-Specific Dosing

  • For enterococcal endocarditis, pediatric dosing is 40 mg/kg/day divided into 2-3 doses 2
  • For Staphylococcus aureus infections (methicillin-resistant), vancomycin should be dosed at 40-60 mg/kg/day divided every 6-8 hours 2
  • For Group A Streptococcal infections, vancomycin can be administered at 40-60 mg/kg/day every 6-8 hours 2
  • For Clostridium difficile infections in children, the maximum dose is 500 mg four times daily (for severe/fulminant cases) 2

Administration Considerations

  • Each dose should be administered over a period of at least 60 minutes to minimize infusion-related reactions 1
  • Concentrations should not exceed 5 mg/mL in pediatric patients to reduce risk of adverse events 1
  • Close monitoring of serum concentrations is recommended, especially in neonates and patients with changing renal function 1, 3

Therapeutic Monitoring

  • Standard empiric dosing of 40-60 mg/kg/day achieves therapeutic trough levels (10-20 mg/L) in only about 39% of pediatric patients 3
  • Research suggests that higher doses may be needed in certain age groups to achieve therapeutic levels:
    • 60 mg/kg/day for patients 1-5 months and 13-18 years of age 3
    • 70 mg/kg/day for patients 6 months to 12 years of age 3, 4
  • Patients with augmented renal clearance may require doses up to 75 mg/kg/day to achieve therapeutic targets 4

Important Considerations

  • Dosage adjustment is necessary in patients with impaired renal function 1
  • In premature infants, vancomycin clearance decreases as postconceptional age decreases, requiring longer dosing intervals 1
  • For patients on extracorporeal membrane oxygenation (ECMO), lower doses (around 30 mg/kg/day) may be sufficient due to altered pharmacokinetics 5
  • The FDA-approved vancomycin label specifically states that pediatric dosing should not exceed that of a normal adult 1

Pitfalls to Avoid

  • Using adult dosing regimens in pediatric patients without adjustment can lead to subtherapeutic levels 3, 6
  • Failing to monitor trough concentrations may result in treatment failure or toxicity 1, 3
  • Not adjusting doses based on renal function can increase the risk of nephrotoxicity 1
  • Standard dosing of 40 mg/kg/day is often insufficient to achieve therapeutic trough levels above 10 mg/L in many pediatric patients 6

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Achieving therapeutic vancomycin levels in pediatric patients.

The Canadian journal of hospital pharmacy, 2014

Research

Vancomycin Dosing in Pediatric Extracorporeal Membrane Oxygenation: Potential Impacts of New Technologies.

The journal of pediatric pharmacology and therapeutics : JPPT : the official journal of PPAG, 2017

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.